SavedAdd your journal

Journals / Journal of Neurological Sciences (Turkish) / 2006 / Cilt: 23 - Sayı: 2

Metabolic syndrome in cerebrovascular diseases

Serebrovasküler hastalıklarda metabolik sendrom

Figen VARLIBAŞ
Hülya TİRELİ
Cihat ÖRKEN
Nursen ÇAKAL
Mehmet GENÇER
Pages
93–101
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We decided metabolic syndrome in the presence of three or more of five items of the diagnostic criteria of the "National Cholesterol Education Program Adult Treatment Panel III " .Results: The incidence of metabolic syndrome in ischemic patients (67,2%) was significantly higher than hemorrhagic ones (33,3%) (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The term "metabolic syndrome" has been proposed to define a cluster of several risk factors for cardiovascular disease.
📊
Key Findings & Data:Methods: Ischemic cerebrovascular patients were grouped on the basis of the "Trial of Org 10172 in Acute Stroke Treatment" study; and the ones with a specific cause, cryptogenic stroke, and inconclusive cases were not included in the study.
💡
Conclusion & Impact:We decided metabolic syndrome in the presence of three or more of five items of the diagnostic criteria of the "National Cholesterol Education Program Adult Treatment Panel III " .Results: The incidence of metabolic syndrome in ischemic patients (67,2%) was significantly higher than hemorrhagic ones (33,3%) (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The term "metabolic syndrome" has been proposed to define a cluster of several risk factors for cardiovascular disease. We investigated the existence of metabolic syndrome in acute period cerebrovascular patients and its relationship with acute mortality. Methods: Ischemic cerebrovascular patients were grouped on the basis of the "Trial of Org 10172 in Acute Stroke Treatment" study; and the ones with a specific cause, cryptogenic stroke, and inconclusive cases were not included in the study. Total number of patients was 474 of which 354 were ischemic (including 99 cardioembolic, 147 large arterial atherosclerotic, 108 small vessel occlusion) and 120 were hemorrhagic. We decided metabolic syndrome in the presence of three or more of five items of the diagnostic criteria of the "National Cholesterol Education Program Adult Treatment Panel III " .Results: The incidence of metabolic syndrome in ischemic patients (67,2%) was significantly higher than hemorrhagic ones (33,3%) (p

Özet

Giriş: Metabolik sendrom, kardiyovasküler hastalıklar risk faktörleri topluluğunu tanımlamak için ileri sürülmüş bir terimdir. Bu çalışmada akut dönem serebrovasküler hastalarda metabolik sendrom varlığı ve akut dönem mortalite ile ilişkisi araştırılmıştır. Metodlar: İskemik serebrovasküler hastalar "Trial of Org 10172 in Acute Stroke Treatment" çalışmasına göre gruplandırılmış; belirli bir nedeni olanlar, nedeni belli olmayanlar ve karar verilemeyenler çalışmaya alınmamıştır. İskemik serebrovasküler 354 (kardiyoembolik 99, büyük arter aterosklerozu 147, küçük damar oklüzyonu 108) ve intraserebral hemorajili 120 olmak üzere toplam 474 hasta incelenmiştir. Metabolik sendrom kararı "National Cholesterol Education Program Adult Treatment Panel III" tanı kriterlerine göre beş maddeden üç yada daha fazlasının varlığında verilmiştir.Bulgular: İskemik serebrovasküler hastalarda metabolik sendrom varlığı (%67,2), intraserebral hemorajili hastalardan (%33,3) anlamlı olarak yüksek bulunmuştur (p

🔖

Cite This Article

VARLIBAŞ, F., TİRELİ, H., ÖRKEN, C., ÇAKAL, N., GENÇER, M. (2022). Metabolic syndrome in cerebrovascular diseases. Journal of Neurological Sciences (Turkish), Cilt: 23 - Sayı: 2, 93–101. https://ajindex.com/articles/565672

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24(1): 35-41
  2. Aull S, Lalouschek W, Schnider P, Sinzinger H, Uhl F, Zeiler K. Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke. Am J Med 1996; 101(3): 291-8.
  3. Baltalı M, Kızıltan HT, Korkmaz ME, Topçu S, Demirtaş M, Müderrisoğlu H, Topçuoğlu Ş, Birand A. Koroner baypas sonrası hastalarda metabolik sendrom sıklığı ve tedaviye uyum oranları. Anadolu Kardiyol Derg 2004; 4: 10-16
  4. Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, Joo IS, Huh K. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005; 26;65(2): 296-8
  5. Biessels GJ, Kappelle LJ; Utrecht Diabetic Encephalopathy Study Group. Increased risk of Alzheimer’s disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 2005; 33(5): 1041-4
  6. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck Study. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 2003; 27(10): 1283-9
  7. Bushnell CD, Guzick D. Metabolic syndrome and intracranial atherosclerosis: a new link? Neurology 2005; 26;65(2): 188-9
  8. Ellison RC, Zhang Y, Wagenknecht LE, Eckfeldt JH, Hopkins PN, Pankow JS, Djousse L, Carr JJ. Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta. Am J Cardiol 2005; 15;95(10): 1180-6
  9. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28(7): 1769-78
  10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 16;287(3): 356-9
  11. Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL; SMART Study Group. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 2004; 173(2): 363-9
  12. Grundy SM. Po